Roger A Lobo

Author PubWeight™ 13.79^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.	N Engl J Med	2003	2.63
2	Postmenopausal hormone therapy: an Endocrine Society scientific statement.	J Clin Endocrinol Metab	2010	2.27
3	Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial.	Menopause	2005	1.61
4	A 20-year follow-up of young women with polycystic ovary syndrome.	Obstet Gynecol	2012	0.93
5	Best practices of ASRM and ESHRE: a journey through reproductive medicine.	Fertil Steril	2012	0.87
6	Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women.	Menopause	2010	0.87
7	Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial).	Am J Cardiol	2008	0.86
8	Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT).	Atherosclerosis	2005	0.84
9	Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.	Gynecol Endocrinol	2014	0.81
10	Ovarian adipocytokines are associated with early in vitro human embryo development independent of the action of ovarian insulin.	J Assist Reprod Genet	2012	0.81
11	Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.	Circulation	2003	0.80
12	What is the effect of estrogen on blood pressure after menopause?	Menopause	2006	0.75
13	Words of thanks to Dr. Alan H. DeCherney.	Fertil Steril	2011	0.75